Carfilzomib
-
Catalog number2385-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name(S)-4-methyl-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide; PR-171
-
DescriptionCarfilzomib (PR-171) is a next generation, irreversible and selective inhibitor of the chymotrypsin-like activity of the proteasome. It displays potent antineoplastic activity.
-
CAS Number868540-17-4
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₄₀H₅₇N₅O₇
-
Molecular Weight719.91
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~50 mg/ml)
-
HandlingProtect from light and moisture
-
Tag LineA next generation proteasome inhibitor
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID11556711
-
SMILESCC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4
-
InChiInChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1
-
InChi KeyBLMPQMFVWMYDKT-NZTKNTHTSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameCarfilzomib
-
Alternative nameCarfilzomib
-